Drug
Eos301984
Eos301984: highest development phase Phase 1, developed by iTeos Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- iTeos Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| EOS301984 NCT06547957 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow Eos301984 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.